|
Market Closed -
Nasdaq
04:00:00 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.3351 USD | -9.68% |
|
-29.48% | -94.52% |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
840.gkdw58RzVGVMPK0iVcS700cHEQ8LEWpZCJXUcFn9fcs.6hVCg_FCPQ47COtxeJLovgoxd3hRIFwSZeeQBGGxEIe2dCKoggtiCQVGwg~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +3,386.52% | |||||
| +42.48% | |||||
| +24.46% | |||||
| +8.41% | |||||
| +15.87% | |||||
| +17.86% | |||||
| +35.3% | |||||
| +1.94% | |||||
| +41.27% | |||||
| +72.28% | |||||
| Average | +364.64% | |||||
| Weighted average by Cap. | +27.17% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.3351USD
Average target price
11.68USD
Spread / Average Target
+3,386.52%
High Price Target
15.05USD
Spread / Highest target
+4,391.20%
Low Price Target
8.000USD
Spread / Lowest Target
+2,287.35%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
